Natera Inc (NTRA) is a Healthcare · Diagnostics & Research company listed on NASDAQ. Price $361.62 (-1.28%), Market cap $29.23B, 52-week low–high $133.66 ~ $254.40.
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT, or sgNIPT, that screens for 21 single-gene inherited conditions; and Vistara, a single-g
Financial statements, price targets, institutional (13F) holdings and related news for Natera Inc are updated in real time on BlackAll Trade.
Natera Inc trades at $361.62 (-1.28%). Real-time quotes and charts are available on BlackAll Trade.
Natera Inc has a market cap of about $29.23B.
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment,